By Oliver Gray Investing.com - The S&P/ASX 200 added 32.8 points or 0.5% to 6,998.3 during Tuesday’s trade, partially retracing losses of 2% in the previous session amid broad...
Highlights Bubs doubled its gross revenue to a record AU$104.3 million in FY22. Loss after tax shrank to AU$11.4 million from AU$74.7 million. Bubs’ strong performance...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Originally published by OpenMarkets 2017 – a year that will evoke the memory of Donald Trump and his twitter mania (and of course the Twitter temp who pulled the plug on his...
Bubs Australia Limited is engaged in the business of infant formula, family dairy products and children's nutrition products. The Company produces goat dairy products and organic food products for all ages under the Bubs brand. Its products include cow’s milk formula, goats milk formula, organic baby food, cereals, toddler snacks, Vita Bubs, puree, rusks, infant and children's vitamin and mineral supplements. It also offers children’s vitamin and mineral supplements that are also formulated with goat milk and address immune, bone, digestive and cognitive health concerns parents have for their children. The Company offers goat dairy products and produces goat milk-based formulae for adult everyday use, formulations, and adult immunity support for domestic and export markets. Its products are sold in supermarkets and pharmacies throughout Australia, as well as exported to China, Vietnam, Southeast Asia and the Middle East.
|Average||40.140 (+17,740.000% Upside)|
|No. of Analysts||5|
|Moving Averages||Sell||Sell||Sell||Sell||Strong Sell|
|Technical Indicators||Strong Sell||Sell||Strong Buy||Strong Sell||Strong Sell|
|Summary||Strong Sell||Sell||Neutral||Strong Sell||Strong Sell|